Skip to main content
OpenTrials
Completed

NCT Number: NCT05599321

Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling

The overall goal is to evaluate the role of a Virtual Navigation (VN) system (the Virtual Navigator) in the bronchoscopic evaluation and tissue sampling of lung cancer and other chest lesions at the Penn State Hershey Medical Center (HMC). The Virtual Navigator is a software package that runs on a mobile Windows-based computer. The computer takes in up to four clinical image/video sources, ordered by the clinician for clinical purposes: 1) 3D CT (computed tomography) imaging scan; 2) 3D PET (positron emission tomography) imaging scan (optional); 3) Bronchoscopic video of the airway tree interior; 4) Ultrasound video of scanned anatomy outside the airways, as provided by an endobronchial ultrasound (EBUS) probe (optional). During a live guided procedure, the Virtual Navigator presents images that assist with navigating the bronchoscope to predesignated chest lesions.

Lung cancer patients that present a suspicious peripheral tumor on their chest CT scan are often prescribed to undergo a diagnosis-and-staging bronchoscopy, whereby the bronchoscopist examines both the suspect tumor and any identified central-chest lymph nodes. For the clinical study, we consider bronchoscopy performance for two cohorts: 1) a cohort of consented patients who undergo image-guided bronchoscopy via the Virtual Navigator; and 2) a historical controls cohort consisting of patients who underwent bronchoscopy recently at our medical center (state-of-the-art bronchoscopy practice). The study's general hypothesis is that an image-guided bronchoscopy system (the Virtual Navigator) that integrates 3D imaging, bronchoscopy, and EBUS images enables more complete evaluation and sampling of chest lesions than current state-of-the-art clinical techniques. More specifically, for peripheral-tumor diagnosis, the sub-hypothesis is that the VN system increases diagnostic biopsy yield as compared to state-of-the-art bronchoscopy practice; for central-chest nodal staging, the sub-hypothesis is that the VN system enables the sampling of more lymph nodes than state-of-the-art bronchoscopy practice.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients from age 18 and over
  • a planned clinical bronchoscopy to evaluate abnormal lung parenchyma and/or central chest lymph nodes
  • a clinical CT scan performed at Hershey Medical Center that meets technical specifications and is available on the Radiology research server
  • (Optional, use if available) CT/PET images that meet technical specifications and are available on the Hershey Medical Center clinical image storage system

Exclusion criteria

  • inability to give consent
  • the CT scan does not meet technical specifications

Treatment and study plan

Virtual Navigation System

Diagnostic Test

The Virtual Navigator guidance computer is interfaced to the bronchoscopy hardware to tap off the live bronchoscopy and EBUS video feeds. The standard OR medical team (technicians, clinical fellows, et al.) is on hand, and standard clinical facilities (e.g., fluoroscopy, CT/PET image viewer) are available. Our technical team is also present to record all procedural video and computer display information. It also operates the guidance computer during the guided procedure and offers any assistance in case of unanticipated issues. The participant's clinical bronchoscopy will be recorded by the radiology imaging management system.

Primary outcomes

  1. Safety Measurement

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Presence or absence of adverse events during a procedure

  2. Functionality Measurement

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Presence or absence of software malfunctions in the VN System during bronchoscopic procedure

  3. Diagnostic Biopsy Yield

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Comparison of diagnostic biopsy yield between the historical controls and consented live cases

  4. Radial Endobronchial Ultrasound (EBUS) Probe Passes

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Number of Passes of the Radial Endobronchial Ultrasound (EBUS) Probe per ROI

  5. Comparison of the Number of Lymph Nodes and Nodal Stations Visited

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Comparison of number of lymph nodes and nodal stations visited between the live cases and historical controls

Secondary outcomes

  1. Tumor Pathology

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Whether a sample is malignant, non-malignant, or indeterminate and adequacy of sample

  2. Procedure Complications

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Rate of complications from bronchoscopic procedure

  3. Distance From Final Selected Site to the Pre-planned Optimal Site

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Distance between actual site selected during the live procedure and the pre-planned, computed optimal biopsy site.

  4. Procedure Time

    Time frame: One day. All study related procedures are completed over the course of a day for each participant. There are no follow up visits that occur.

    Procedure time (total and per tumor or lymph node) in minutes

Sponsors and collaborators

Lead sponsor

Penn State University

Other

Collaborators

  • Milton S. Hershey Medical Center

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 31, 2022
Registry last updated
May 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.